Short-term anti-plaque effect of a cymenol mouthwash analysed using the DenTiUS Deep Plaque software: a randomised clinical trial.
Automated plaque quantification
Cymenol
Dental plaque
Image analysis
Mouthwash
Oral health
Prevention
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
12 08 2023
12 08 2023
Historique:
received:
24
03
2023
accepted:
27
07
2023
medline:
16
8
2023
pubmed:
13
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
The effect of cymenol mouthwashes on levels of dental plaque has not been evaluated thus far. To analyse the short-term, in situ, anti-plaque effect of a 0.1% cymenol mouthwash using the DenTiUS Deep Plaque software. Fifty orally healthy participants were distributed randomly into two groups: 24 received a cymenol mouthwash for eight days (test group A) and 26 a placebo mouthwash for four days and a cymenol mouthwash for a further four days thereafter (test group B). They were instructed not to perform other oral hygiene measures. On days 0, 4, and 8 of the experiment, a rinsing protocol for staining the dental plaque with sodium fluorescein was performed. Three intraoral photographs were taken per subject under ultraviolet light. The 504 images were analysed using the DenTiUS Deep Plaque software, and visible and total plaque indices were calculated (ClinicalTrials ID NCT05521230). On day 4, the percentage area of visible plaque was significantly lower in test group A than in test group B (absolute = 35.31 ± 14.93% vs. 46.57 ± 18.92%, p = 0.023; relative = 29.80 ± 13.97% vs. 40.53 ± 18.48%, p = 0.024). In comparison with the placebo, the cymenol mouthwash was found to have reduced the growth rate of the area of visible plaque in the first four days by 26% (absolute) to 28% (relative). On day 8, the percentage areas of both the visible and total plaque were significantly lower in test group A than in test group B (visible absolute = 44.79 ± 15.77% vs. 65.12 ± 16.37%, p < 0.001; visible relative = 39.27 ± 14.33% vs. 59.24 ± 16.90%, p < 0.001; total = 65.17 ± 9.73% vs. 74.52 ± 13.55%, p = 0.007). Accounting for the growth rate with the placebo mouthwash on day 4, the above results imply that the cymenol mouthwash in the last four days of the trial reduced the growth rate of the area of visible plaque (absolute and relative) by 53% (test group A) and 29% (test group B), and of the area of total plaque by 48% (test group A) and 41% (test group B). The 0.1% cymenol mouthwash has a short-term anti-plaque effect in situ, strongly conditioning the rate of plaque growth, even in clinical situations with high levels of dental plaque accumulation.
Sections du résumé
BACKGROUND
The effect of cymenol mouthwashes on levels of dental plaque has not been evaluated thus far.
OBJECTIVE
To analyse the short-term, in situ, anti-plaque effect of a 0.1% cymenol mouthwash using the DenTiUS Deep Plaque software.
METHODS
Fifty orally healthy participants were distributed randomly into two groups: 24 received a cymenol mouthwash for eight days (test group A) and 26 a placebo mouthwash for four days and a cymenol mouthwash for a further four days thereafter (test group B). They were instructed not to perform other oral hygiene measures. On days 0, 4, and 8 of the experiment, a rinsing protocol for staining the dental plaque with sodium fluorescein was performed. Three intraoral photographs were taken per subject under ultraviolet light. The 504 images were analysed using the DenTiUS Deep Plaque software, and visible and total plaque indices were calculated (ClinicalTrials ID NCT05521230).
RESULTS
On day 4, the percentage area of visible plaque was significantly lower in test group A than in test group B (absolute = 35.31 ± 14.93% vs. 46.57 ± 18.92%, p = 0.023; relative = 29.80 ± 13.97% vs. 40.53 ± 18.48%, p = 0.024). In comparison with the placebo, the cymenol mouthwash was found to have reduced the growth rate of the area of visible plaque in the first four days by 26% (absolute) to 28% (relative). On day 8, the percentage areas of both the visible and total plaque were significantly lower in test group A than in test group B (visible absolute = 44.79 ± 15.77% vs. 65.12 ± 16.37%, p < 0.001; visible relative = 39.27 ± 14.33% vs. 59.24 ± 16.90%, p < 0.001; total = 65.17 ± 9.73% vs. 74.52 ± 13.55%, p = 0.007). Accounting for the growth rate with the placebo mouthwash on day 4, the above results imply that the cymenol mouthwash in the last four days of the trial reduced the growth rate of the area of visible plaque (absolute and relative) by 53% (test group A) and 29% (test group B), and of the area of total plaque by 48% (test group A) and 41% (test group B).
CONCLUSIONS
The 0.1% cymenol mouthwash has a short-term anti-plaque effect in situ, strongly conditioning the rate of plaque growth, even in clinical situations with high levels of dental plaque accumulation.
Identifiants
pubmed: 37573292
doi: 10.1186/s12903-023-03256-9
pii: 10.1186/s12903-023-03256-9
pmc: PMC10422750
doi:
Substances chimiques
Mouthwashes
0
Chlorhexidine
R4KO0DY52L
Banques de données
ClinicalTrials.gov
['NCT05521230']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
560Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Peres MA, Macpherson LMD, Weyant RJ, Daly B, Venturelli R, Mathur MR, et al. Oral diseases: a global public health challenge. Lancet. 2019;394(10194):249–60.
pubmed: 31327369
Chapple ILC, Van der Weijden F, Doerfer C, Herrera D, Shapira L, Polak D, et al. Primary prevention of periodontitis: managing gingivitis. J Clin Periodontol. 2015;42(Suppl 16):71–6.
Sheiham A, James WPT. Diet and dental caries: the pivotal role of free sugars reemphasized. J Dent Res. 2015;94(10):1341–7.
pubmed: 26261186
Figuero E, Nóbrega DF, García-Gargallo M, Tenuta LMA, Herrera D, Carvalho JC. Mechanical and chemical plaque control in the simultaneous management of gingivitis and caries: a systematic review. J Clin Periodontol. 2017;44(Suppl 18):116–34.
Barnett ML. The rationale for the daily use of an antimicrobial mouthrinse. J Am Dent Assoc. 2006;137(Suppl):16–21.
Paraskevas S. Randomized controlled clinical trials on agents used for chemical plaque control. Int J Dent Hyg. 2005;3(4):162–78.
pubmed: 16451305
Parkinson CR, Hara AT, Nehme M, Lippert F, Zero DT. A randomised clinical evaluation of a fluoride mouthrinse and dentifrice in an in situ caries model. J Dent. 2018;70:59–66.
pubmed: 29289727
Meyerowitz C, Featherstone JD, Billings RJ, Eisenberg AD, Fu J, Shariati M, et al. Use of an intra-oral model to evaluate 0.05% sodium fluoride mouthrinse in radiation-induced hyposalivation. J Dent Res. 1991;70(5):894–8.
pubmed: 2022771
Figuero E, Roldán S, Serrano J, Escribano M, Martín C, Preshaw PM. Efficacy of adjunctive therapies in patients with gingival inflammation: a systematic review and meta-analysis. J Clin Periodontol. 2020;47(Suppl 22):125–43.
pubmed: 31869441
Jepsen S, Blanco J, Buchalla W, Carvalho JC, Dietrich T, Dörfer C, et al. Prevention and control of dental caries and periodontal diseases at individual and population level: consensus report of group 3 of joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J Clin Periodontol. 2017;44(Suppl 18):85–93.
Takenaka S, Ohsumi T, Noiri Y. Evidence-based strategy for dental biofilms: current evidence of mouthwashes on dental biofilm and gingivitis. Jpn Dent Sci Rev. 2019;55(1):33–40.
pubmed: 30733843
Ramsey JT, Shropshire BC, Nagy TR, Chambers KD, Li Y, Korach KS. Essential oils and health. Yale J Biol Med. 2020;93(2):291–305.
pubmed: 32607090
pmcid: 7309671
Alshehri FA. The use of mouthwash containing essential oils (LISTERINE®) to improve oral health: a systematic review. Saudi Dent J. 2018;30(1):2–6.
pubmed: 30166864
Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol. 2004;31(10):878–84.
pubmed: 15367192
Figuero E, Herrera D, Tobías A, Serrano J, Roldán S, Escribano M, et al. Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and network meta-analyses. J Clin Periodontol. 2019;46(7):723–39.
pubmed: 31058336
Alpaslan Yayli NZ, Tunc SK, Degirmenci BU, Dikilitas A, Taspinar M. Comparative evaluation of the cytotoxic effects of different oral antiseptics: a primary culture study. Niger J Clin Pract. 2021;24(3):313–20.
pubmed: 33723103
Brookes ZLS, Bescos R, Belfield LA, Ali K, Roberts A. Current uses of chlorhexidine for management of oral disease: a narrative review. J Dent. 2020;103:103497.
pubmed: 33075450
pmcid: 7567658
Mao X, Auer DL, Buchalla W, Hiller K, Maisch T, Hellwig E, et al. Cetylpyridinium chloride: mechanism of action, antimicrobial efficacy in biofilms, and potential risks of resistance. Antimicrob Agents Chemother. 2020;64(8):576.
Diao W, Zhang L, Feng S, Xu J. Chemical composition, antibacterial activity, and mechanism of action of the essential oil from amomum kravanh. J Food Prot. 2014;77(10):1740–6.
pubmed: 25285491
Hąc-Wydro K, Flasiński M, Broniatowski M, Sołtys M. Studies on the behavior of eucalyptol and terpinen-4-ol-natural food additives and ecological pesticides-in model lipid membranes. Langmuir. 2017;33(27):6916–24.
pubmed: 28654274
Burnett GR, Stephen AS, Pizzey RL, Bradshaw DJ. In vitro effects of novel toothpaste actives on components of oral malodour. Int Dent J. 2011;61(Suppl 3):67–73.
pubmed: 21762158
Pizzey RL, Marquis RE, Bradshaw DJ. Antimicrobial effects of o-cymen-5-ol and zinc, alone & in combination in simple solutions and toothpaste formulations. Int Dent J. 2011;61(Suppl 3):33–40.
pubmed: 21762153
Churchley D, Newby CS, Willson R, Haider A, Schemehorn B, Lynch RJM. Protection against enamel demineralisation using toothpastes containing o-cymen-5-ol, zinc chloride and sodium fluoride. Int Dent J. 2011;61(Suppl 3):55–9.
pubmed: 21762156
Yang J, Deol G, Myangar N. Retention of o-cymen-5-ol and zinc on reconstructed human gingival tissue from a toothpaste formulation. Int Dent J. 2011;61(Suppl 3):41–5.
pubmed: 21762154
Kakar A, Newby EE, Kakar K, Ghosh S, Targett D, Bosma ML. A randomised clinical trial to assess maintenance of gingival health by a novel dentifrice containing 0.1%w/w o-cymen-5-ol and 0.6%w/w zinc chloride. Int Dent J. 2011;61(Suppl 3):13–20.
pubmed: 21762150
Kakar A, Newby EE, Ghosh S, Butler A, Bosma ML. A randomised clinical trial to assess maintenance of gingival health by a novel gel to foam dentifrice containing 0.1%w/w o-cymen-5-ol, 0.6%w/w zinc chloride. Int Dent J. 2011;61(Suppl 3Suppl 3):21–7.
pubmed: 21762151
Mira FJ, Sobrino MD, Cuadras FV, Notario IZ. Eficacia frente al sangrado gingival de una pasta dental con o-cymen5-ol. Cient Dent. 2020;17(1):41–8.
Mira J, Vivancos F, Porcar M, Pascual J. Estudio de prueba de concepto sobre la eficacia de una pasta dental y un colutorio para hacer frente simultáneamente a gingivitis e hiperestesia dental. RCOE. 2022;27(2):235–42.
López Jornet P, Hernandez L, Gomez García F, Galera Molero F, Pons-Fuster López E, Tvarijonaviciute A. A clinical study on the efficacy and tolerability of a new topical gel and toothpaste in patients with xerostomia: a randomized controlled trial. J Clin Med. 2021;10(23):5641.
pubmed: 34884343
pmcid: 8658424
Aguilera F, Viñas M, Sierra JM, Vinuesa T, Fernandez de Henestrosa AR, Furmanczyk M, et al. Substantivity of mouth-rinse formulations containing cetylpyridinium chloride and o-cymen-5-ol: a randomized-crossover trial. BMC Oral Health. 2022;22(1):646.
pubmed: 36575444
pmcid: 9793821
Payne D, Gordon JJ, Nisbet S, Karwal R, Bosma ML. A randomised clinical trial to assess control of oral malodour by a novel dentifrice containing 0.1%w/w o-cymen-5-ol, 0.6%w/w zinc chloride. Int Dent J. 2011;61(Suppl 3):60–6.
pubmed: 21762157
Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of victamine c. J Periodontol. 1970;41(1):41–3.
pubmed: 5264376
Butler BL, Morejon O, Low SB. An accurate, time-efficient method to assess plaque accumulation. J Am Dent Assoc. 1996;127(12):1763–85.
pubmed: 8990746
Sagel PA, Lapujade PG, Miller JM, Sunberg RJ. Objective quantification of plaque using digital image analysis. Monogr Oral Sci. 2000;17:130–43.
pubmed: 10949837
Carter K, Landini G, Walmsley AD. Automated quantification of dental plaque accumulation using digital imaging. J Dent. 2004;32(8):623–8.
pubmed: 15476956
You W, Hao A, Li S, Wang Y, Xia B. Deep learning-based dental plaque detection on primary teeth: a comparison with clinical assessments. BMC Oral Health. 2020;20(1):141.
pubmed: 32404094
pmcid: 7222297
Vila-Blanco N, Freire V, Balsa-Castro C, Tomás I, Carreira MJ. DenTiUS plaque, a web-based application for the quantification of bacterial plaque: development and usability study. J Med Internet Res. 2020;22(9):e18570.
pubmed: 32663148
pmcid: 7499169
Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. 2018;89(Suppl 1):173–82.
R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. 2022; Available at: https://www.R-project.org/ .
Faul F, Erdfelder E, Lang A, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.
pubmed: 17695343
Regueira-Iglesias A, Blanco T, Freire V, Balsa-Castro C, Carreira MJ, Tomás I. High validity of dental plaque indices by imaging analysis. Poster session presented at IADR/PER General Session & Exhibition 2018. 96th General Session of the International Association for Dental Research and the Pan European Regional Congress; 2018 Jul 25–28; London, LDN, UK. Available at: https://iadr.abstractarchives.com/abstract/18iags-2960545/high-validity-of-dental-plaque-indices-by-imaging-analysis .
Varas-Quintana P, Aneiros-Ardao A, Balsa-Castro C, Vila-Blanco N, Carreira MJ, Tomás I. In situ evolution pattern of dental plaque through plaque indices by imaging analysis. Poster session presented at CED-IADR/NOF Oral Health Research Congress 2019. Continental European and Scandinavian Divisions of the International Association for Dental Research Meeting; 2019 Sep 19–21; Madrid, CM, ES. Available at: https://iadr.abstractarchives.com/abstract/ced-iadr2019-3223518/in-situ-evolution-pattern-of-dental-plaque-through-plaque-indices-by-imaging-analysis .
Haas AN, Wagner TP, Muniz FWilkerM, Gomes, Fiorini T, Cavagni J, Celeste RK. Essential oils-containing mouthwashes for gingivitis and plaque: meta-analyses and meta-regression. J Dent. 2016;55:7–15.
pubmed: 27628316
Iqbal MP, Siddiqui MI, Kausar L, Iqbal MJ. Difference in plaque removal from buccal & lingual surfaces of teeth by manual brushing. PJMHS. 2015;9(3):986–8.
Carvalho AP, Moura MF, Costa FO, Cota LO. Correlations between different plaque indexes and bleeding on probing: a concurrent validity study. J Clin Exp Dent. 2023;15(1):e9–e16.
pubmed: 36755682
pmcid: 9899362
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.